1′-substituted-carba-nucleoside prodrugs for antiviral treatment
US8415308B2 · kind B2 · utility
92Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2011 |
| Grant date | Apr 9, 2013 |
| Priority date | — |
| Expiry date | May 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are prodrugs of pyrrolo[1,2-f][1,2,4]triazin-7-yl nucleoside phosphates wherein the 1′ position of the nucleoside sugar is substituted with CN. The compounds, compositions, and methods provided are useful for the treatment Hepatitis C infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.